The Newcastle upon Tyne Hospitals Foundation Trust is one of the largest NHS trusts in the UK, covering six hospitals.
Elodie and her team in the department of blood sciences perform over 10 million tests each year, providing a service over two sites: the Freeman Hospital and the Royal Victoria Infirmary.
Previously they were using Phadia EliA I, but the launch of the Phadia EliA II led to a review of their calprotectin method. They decided to evaluate both the Phadia EliA II and the BÜHLMANN fCAL® turbo calprotectin assays.
Elodie explains the evaluation and the reasons behind the change to the BÜHLMANN fCAL turbo method.
Read the full case study here
